VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (Paris:AMPLI), a leading French player on the global surgical technology market for lower-limb orthopedics, announces the appointment of Mrs. Muriel Benedetto Marmilloud to the newly-created position of Chief Operating Officer (COO). She will report directly to Olivier Jallabert, Chairman and CEO of Amplitude Surgical.
Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “All of Amplitude Surgical’s staff members and I are delighted to welcome Muriel Benedetto Marmilloud to the newly-created position of Chief Operating Officer. Muriel is a senior executive who is recognized for her focus on innovation and her knowledge of global markets – in particular the US market. Her experience and strategic vision will be very valuable to our Group’s future growth, its global deployment and the expansion of its portfolio of innovative products”.
Graduated from the ECAM engineering school in Lyon, Muriel Benedetto Marmilloud has over twenty years of experience in the orthopedic medical device sector. She has notably been the global director of a product line generating over a billion-dollar at Zimmer Biomet, the global leader of this sector.
Muriel Benedetto Marmilloud will work alongside Chairman and CEO Olivier Jallabert, more focused on the Group’s strategic developments, and in particular international development. She will be in charge of steering the R&D, Supply chain and Quality assurance & Regulatory affairs departments, in order to ensure total control over the entire logistics value chain. Working in close collaboration with the current teams, she will also be responsible for continuing the structuring of operations in order to accompany the Company’s international development and comply with future regulatory changes.
About Amplitude Surgical
Founded in 1997 in Valence, France,
Amplitude Surgical is a leading French player on the global surgical
technology market for lower-limb orthopedics. Amplitude Surgical
develops and markets high-end products for orthopedic surgery covering
the main disorders affecting the hip, knee and extremities, and notably
foot and ankle surgery. Amplitude Surgical develops, in close
collaboration with surgeons, numerous high value-added innovations in
order to best meet the needs of patients, surgeons and healthcare
facilities. A leading player in France, Amplitude Surgical is developing
abroad through its subsidiaries and a network of exclusive distributors
and agents distributing its products in more than 30 countries.
Amplitude Surgical operates on the lower-limb market through the
intermediary of its Novastep subsidiaries in France and the United
States. At June 30, 2018, Amplitude Surgical had a workforce of nearly
400 employees and recorded sales of over 100 million euros.